ArticleLaboratory investigation; a journal of technical methods and pathology2019

Anti-cancer effect of doxorubicin is mediated by downregulation of HMG-Co A reductase via inhibition of EGFR/Src pathway.

Un-Jung Yun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.